AIM Vaccine Co., Ltd.

Market Cap: N/A
Industry: Pharmaceuticals & Biotechnology
ISIN: CNE100005KF2

HKD

3.51

0.14 (4.15%)

Dec 12

HKG

Click here to see other stocks

Score

Click here to find our call on this stock

Strong Sell

Sell

Hold

Buy

Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.Unlock 29 Markets

Comparison

Company

Score

Quality

Valuation

Financial

Technical

Wuxi Biologics (Cayman), Inc.

3SBio, Inc.

Alphamab Oncology

CSPC Pharmaceutical Group Ltd.

Sirnaomics Ltd.

Zai Lab Ltd.

Ascentage Pharma Group International Co., Ltd.

Laekna, Inc.

Beijing Lüzhu Biotechnology Co., Ltd.

AIM Vaccine Co., Ltd.

Genscript Biotech Corp.

Why is AIM Vaccine Co., Ltd. ?

Weak Long Term Fundamental Strength with an average Return on Capital Employed (ROCE) of 0%

Poor long term growth as Operating profit has grown by an annual rate 0.00% of over the last 5 years
High Debt Company with a Debt to Equity ratio (avg) at times

Flat results in Dec 24

INTEREST(HY) At HKD 33.41 MM has Grown at 25.33%
NET PROFIT(Q) At HKD -114.16 MM has Fallen at -114.39%

Risky -

The stock is trading risky as compared to its average historical valuations
Over the past year, while the stock has generated a return of -49.35%, its profits have risen by 32%

Consistent Underperformance against the benchmark over the last 3 years

Along with generating -49.35% returns in the last 1 year, the stock has also underperformed Hang Seng Hong Kong in each of the last 3 annual periods

Real-Time Research Report

Verdict Report

How much should you sell?

All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is AIM Vaccine Co., Ltd. for you?

High Risk, Low Return

Absolute

Risk Adjusted

Volatility

AIM Vaccine Co., Ltd.

-49.35%

-0.77

63.41%

Hang Seng Hong Kong

27.36%

1.06

25.88%

Quality

Management Risk

Growth

Capital Structure

Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor

Value

Sales Growth (5y)

0.00%

EBIT Growth (5y)

0.00%

EBIT to Interest (avg)

-7.50

Debt to EBITDA (avg)

Negative Net Debt

Net Debt to Equity (avg)

0.35

Sales to Capital Employed (avg)

0.20

Tax Ratio

4.21%

Dividend Payout Ratio

Pledged Shares

Institutional Holding

ROCE (avg)

ROE (avg)

Valuation

Valuation Scorecard

Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors

Factor

Value

P/E Ratio

NA (Loss Making)

Industry P/E

Price to Book Value

0.69

EV to EBIT

-15.08

EV to EBITDA

-60.82

EV to Capital Employed

0.77

EV to Sales

2.68

PEG Ratio

Dividend Yield

ROCE (Latest)

-5.11%

ROE (Latest)

-7.44%

Technicals

Technical key factors

Indicator

Weekly

Monthly

MACD

Bearish

Mildly Bullish

RSI

No Signal

Bollinger Bands

Mildly Bearish

Moving Averages

Bearish (Daily)

KST

Bearish

Dow Theory

Mildly Bullish

No Trend

OBV

Mildly Bullish

No Trend

Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned

Technical Movement

Analyse All Technical Factors

Financial Trend

Financial Trend Scorecard

Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

Not enough Data to analyse Financial Trend

Here's what is not working for AIM Vaccine Co., Ltd.

Net Profit

At HKD -114.16 MM has Fallen at -114.39%

Year on Year (YoY)

MOJO Watch

Near term Net Profit trend is very negative

Net Profit (HKD MM)

Interest

At HKD 33.41 MM has Grown at 25.33%

over previous Semi-Annual period

MOJO Watch

Rising interest cost signifies increased borrowings

Interest Paid (HKD MM)